Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The CCI is higher in CKD 5 patients than CKD 1 to 4 patients (4.0 ± 1.8 vs. 1.7 ± 1.7, p < 0.001). 9482 (74%) CKD patients had at least three comorbidities. 2059 (16%) CKD 5 patients had vitamin D, 4362 (34%) calcium acetate, 455 (4%) ca carbonate, 934 (7%) magnesium oxide, 6944 (54%) folic acid, and 3383 (26%) vitamin B. 6179 (3.0%) of CKD 1 to 4 patients had hip fractures in 890302 patient-year, and 632 (4.9%) of CKD 5 patients had hip fractures in 45056 patient-year.

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

CKD 5 ND patients were identified using the prescription of erythropoiesis-stimulating agents (ATC code B03XA01 and B03XA02) because these medications were only prescribed to patients with an estimated glomerular filtration rate less than 15 ml/min/1.73 m2.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Hip fracture in patients with non-dialysis chronic kidney disease stage 5

Study design awaiting verification · Scientific Reports · 2021

Original publication title

Hip fracture in patients with non-dialysis chronic kidney disease stage 5

Chao-Hsiun Tang; Che-Yi Chou

© The Author(s) 2021

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Hip fracture is a significant health problem and is associated with increased mortality. Patients with chronic kidney disease (CKD) are more at risk of hip fracture than the general population, but the hip fracture risk is not evident among non-dialysis CKD stage 5 patients. This study aims to assess the risk of hip fracture in patients with non-dialysis CKD stage 5 comparing to those with CKD stages 1 to 4. Patients with non-dialysis CKD stage 5 and CKD stages 1 to 4 were retrieved from Taiwan longitudinal health insurance database 2011 to 2014.

All patients were followed to the end of 2018 for the development of hip fractures. We analyze the risk of hip fracture of propensity score-matched patients with CKD stage 5 compared to patients with CKD stages 1 to 4 using stepwise Cox regression and competing risks regression. We analyzed 5649 propensity score-matched non-dialysis CKD 1 to 4 patients and non-dialysis CKD 5 patients between 2011 and 2014. All patients were followed to the end of 2018, 229 (4.1%) of CKD 1 to 4 patients in 21,899 patient-year, and 290 (5.1%) of CKD 5 patients had hip fractures in 18,137 patient-year.

CKD 5 patients had a higher risk of hip fracture than patients with CKD stages 1 to 4. The adjusted HR was 1.53 (95% CI 1.08 to 1.54) in the Cox regression with adjustments for age, gender, comorbidity, and history of fracture. In the competing risks regression, the subdistribution hazard ratio was 1.29 (95% CI 1.08 to 1.54). Female gender, age, history of fractures, and Charlson: Deyo comorbidity index were independently associated with increased hip fracture risks. Non-dialysis CKD 5 patients had a higher risk of hip fracture than patients with CKD stages 1 to 4.

This association is independent of patients’ age, female gender, history of fractures, and comorbidities.

Authors’ abstract

Hip fracture is a significant health problem and is associated with increased mortality. Patients with chronic kidney disease (CKD) are more at risk of hip fracture than the general population, but the hip fracture risk is not evident among non-dialysis CKD stage 5 patients. This study aims to assess the risk of hip fracture in patients with non-dialysis CKD stage 5 comparing to those with CKD stages 1 to 4. Patients with non-dialysis CKD stage 5 and CKD stages 1 to 4 were retrieved from Taiwan longitudinal health insurance database 2011 to 2014.

All patients were followed to the end of 2018 for the development of hip fractures. We analyze the risk of hip fracture of propensity score-matched patients with CKD stage 5 compared to patients with CKD stages 1 to 4 using stepwise Cox regression and competing risks regression. We analyzed 5649 propensity score-matched non-dialysis CKD 1 to 4 patients and non-dialysis CKD 5 patients between 2011 and 2014. All patients were followed to the end of 2018, 229 (4.1%) of CKD 1 to 4 patients in 21,899 patient-year, and 290 (5.1%) of CKD 5 patients had hip fractures in 18,137 patient-year.

CKD 5 patients had a higher risk of hip fracture than patients with CKD stages 1 to 4. The adjusted HR was 1.53 (95% CI 1.08 to 1.54) in the Cox regression with adjustments for age, gender, comorbidity, and history of fracture. In the competing risks regression, the subdistribution hazard ratio was 1.29 (95% CI 1.08 to 1.54). Female gender, age, history of fractures, and Charlson: Deyo comorbidity index were independently associated with increased hip fracture risks. Non-dialysis CKD 5 patients had a higher risk of hip fracture than patients with CKD stages 1 to 4.

This association is independent of patients’ age, female gender, history of fractures, and comorbidities.

Publication and source details

Original title: Hip fracture in patients with non-dialysis chronic kidney disease stage 5

Chao-Hsiun Tang; Che-Yi Chou

Scientific Reports · 2021

© The Author(s) 2021https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Asia University HospitalAUH-10651015Tang Chao-Hsiun

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T11:27:45.933923+00:00

DOI: 10.1038/s41598-021-00157-1 · PMC8523559